# Concentric Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/concentric-medical

- Industry: Medical Devices & Equipment
- Headquarters: Mountain View, US
- Website: www.concentric-medical.com
- Total disclosed funding: $15M
- Latest round: Series E (Dec 18, 2008)
- Investors on record: 3

## About

Concentric Medical, Inc. is a medical device company focused on developing innovative solutions for neurovascular diseases. Their products aim to enhance treatment efficiency and patient outcomes across healthcare settings.Concentric Medical, Inc. specializes in neurovascular access technologies. Founded in 1999 in Mountain View, US, the company was acquired by Stryker Corporation in October 2011 for USD 135 mn. The acquisition marked a significant pivot in its operational strategy, aligning with Stryker's portfolio of advanced medical technologies. The company has engaged in five notable deals, indicating its strategic growth. No subsidiaries or parent companies are reported.Stryker is recognized for its extensive range of advanced medical technology products and solutions, primarily specializing in medical and surgical equipment, orthopaedics, and neurotechnology. The company's flagship products include the Incompass™ Total Ankle System, designed for patients with severely damaged ankle joints, and the AXS Lift Intracranial Base Catheter, which simplifies neurovascular access for interventional therapies. Stryker's offerings also encompass a purpose-built small vessel and arteriovenous (AV) access thrombectomy system, aimed at delivering rapid and comprehensive clot removal. The company serves a diverse clientele, including hospitals, ambulatory surgery centers, and healthcare providers across various geographical markets such as North America, Europe, Asia-Pacific, and Latin America, impacting over 150 million patients annually.Stryker generates revenue through a multi-faceted transaction structure that includes direct sales to healthcare providers, partnerships with hospitals, and distribution through surgical technology wholesalers. The company's revenue model features a range of services, encompassing both equipment sales and ongoing support for its medical devices. Transactions may involve one-time purchases of proprietary devices such as the Incompass™ Total Ankle System or the AXS Lift Catheter, alongside subscription-based services for ongoing training and maintenance. Pricing structures are aligned with the high-value medical technologies Stryker provides, ensuring that healthcare providers can access innovative solutions tailored to improve patient outcomes while effectively managing their operational needs.The acquisition of Concentric Medical, Inc. by Stryker Corporation will facilitate the integration of advanced neurovascular solutions into Stryker's existing product lines. Future growth strategies may include the development and introduction of new neurovascular products, leveraging the expertise gained from Concentric's innovations. Expansion into emerging markets, particularly in Asia-Pacific and Latin America, is anticipated to enhance Stryker's market presence by 2015. The funding from the most recent deal will be utilized to support these product developments and market expansion initiatives.

## Funding rounds

- Series E, Dec 18, 2008, $15M — New Enterprise Associates, SV Health Investors, ProQuest Investments

## Investors

- New Enterprise Associates (https://capitalatlas.ai/funds/new-enterprise-associates) — Series E
- SV Health Investors (https://capitalatlas.ai/funds/sv-health-investors) — Series E
- ProQuest Investments (https://capitalatlas.ai/funds/proquest-investments) — Series E